{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:26:09Z","timestamp":1780579569454,"version":"3.54.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Beeson Career Development Award Program","award":["NIA K08AG048321"],"award-info":[{"award-number":["NIA K08AG048321"]}]},{"DOI":"10.13039\/100000965","name":"American Federation for Aging Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000909","name":"John A. Hartford Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004426","name":"Atlantic Philanthropies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jagp.2016.03.006","type":"journal-article","created":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T06:01:50Z","timestamp":1460354510000},"page":"1000-1003","source":"Crossref","is-referenced-by-count":17,"title":["Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States"],"prefix":"10.1016","volume":"24","author":[{"given":"Donovan T.","family":"Maust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Bonar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Ilgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic C.","family":"Blow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C.","family":"Kales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2016.03.006_bib0010","author":"Center for Behavioral Health Statistics and Quality"},{"key":"10.1016\/j.jagp.2016.03.006_bib0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.annepidem.2005.08.003","article-title":"Projecting drug use among aging baby boomers in 2020","volume":"16","author":"Colliver","year":"2006","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jagp.2016.03.006_bib0020","author":"ProCon.org"},{"key":"10.1016\/j.jagp.2016.03.006_bib0025","doi-asserted-by":"crossref","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jagp.2016.03.006_bib0030","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3390\/ph3082689","article-title":"Cannabinoids and dementia: a review of clinical and preclinical data","volume":"3","author":"Walther","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jagp.2016.03.006_bib0035","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1212\/WNL.0000000000001675","article-title":"Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: a randomized controlled trial","volume":"84","author":"van den Elsen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2016.03.006_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JAD-150915","article-title":"Safety and efficacy of medical cannabis oil for behavioral and psychological symptoms of dementia: an-open label, add-on, pilot study","volume":"51","author":"Shelef","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2016.03.006_bib0045","author":"Michigan Medical Marihuana Registry Program"},{"key":"10.1016\/j.jagp.2016.03.006_bib0050","author":"Department of Health, Government of the District of Columbia"},{"key":"10.1016\/j.jagp.2016.03.006_bib0055","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jagp.2016.03.006_bib0060","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1001\/jama.2015.6199","article-title":"Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review","volume":"313","author":"Hill","year":"2015","journal-title":"JAMA"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748116300616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748116300616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T12:56:43Z","timestamp":1536843403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748116300616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1064748116300616"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2016.03.006","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}